SET Announcements | Interpharma Group (IP)

Financial Performance Quarter 2 (F45) (Reviewed)

Financial Statement Quarter 2/2021 (Reviewed)

Notification of the right to subscribe for the newly issued ordinary shares of the Company on website

Notification on an extension of subscription period (edit)

Notification on an extension of subscription period

Shareholders meeting's resolution

Report on the utilization of capital increased from initial public offering

Publication Notice to the EGM of Shareholders No. 1/2021 Electronic Devices (E-Meeting) on the Company website

Notification of Resolution of the BOD Mtg. regarding the schedule of the EGM No. 1/2021, Capital Increase through Rights Offering & General Mandate, & the Issuance and Offering of the Warrants to Purchase Ordinary Shares of the Company (edit)

Notification of Resolution of the BOD Mtg. regarding the schedule of the EGM No. 1/2021, Capital Increase through Rights Offering & General Mandate, & the Issuance and Offering of the Warrants to Purchase Ordinary Shares of the Company (edit)

Notification of Resolution of the BOD Mtg. regarding the schedule of the EGM No. 1/2021, Capital Increase through Rights Offering & General Mandate, & the Issuance and Offering of the Warrants to Purchase Ordinary Shares of the Company (edit)

Notification of Resolution of the BOD Mtg. regarding the schedule of the EGM No. 1/2021, Capital Increase through Rights Offering & General Mandate, & the Issuance and Offering of the Warrants to Purchase Ordinary Shares of the Company